Avanza Medical Limited 13612863 false 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is provision of general medical activities Digita Accounts Production Advanced 6.30.9574.0 true 13612863 2023-10-01 2024-09-30 13612863 2024-09-30 13612863 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 13612863 bus:Micro-entities 2023-10-01 2024-09-30 13612863 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 13612863 bus:FilletedAccounts 2023-10-01 2024-09-30 13612863 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 13612863 bus:RegisteredOffice 2023-10-01 2024-09-30 13612863 bus:Director1 2023-10-01 2024-09-30 13612863 bus:Director2 2023-10-01 2024-09-30 13612863 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 13612863 countries:EnglandWales 2023-10-01 2024-09-30 13612863 2022-10-01 2023-09-30 13612863 2023-09-30 13612863 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 iso4217:GBP xbrli:pure

Registration number: 13612863

Avanza Medical Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 September 2024

 

Avanza Medical Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3

 

Avanza Medical Limited

Company Information

Directors

Avanus Lih Cherng Hong

Wei Teen Jong

Registered office

Flat 7 Woodlands Court
18 Dashwood Road
Gravesend, Kent
DA11 7DA

 

Avanza Medical Limited

(Registration number: 13612863)
Balance Sheet as at 30 September 2024

2024
£

2023
£

Current assets

8,959

11,056

Creditors: Amounts falling due within one year

(6,679)

(2,052)

Total assets less current liabilities

2,280

9,004

Accruals and deferred income

(250)

(250)

 

2,030

8,754

Capital and reserves

2,030

8,754

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 7 October 2024 and signed on its behalf by:
 

Avanus Lih Cherng Hong
Director

   
     
 

Avanza Medical Limited

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Flat 7 Woodlands Court
18 Dashwood Road
Gravesend, Kent
DA11 7DA

These financial statements were authorised for issue by the Board on 7 October 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

These financial statements have been prepared in UK Pound Sterling (£).

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).